Controveries in Urologic Cancer

Controversies in Urologic Cancer

April 27, 2018

How can you be sure you’ve selected the best approach for your patients with urologic cancer? As our experts debate developments like MRI fusion biopsy for PCa, HIFU for low-risk prostate cancer, and white light cystoscopy, learn how you can integrate these treatments into your practice.

Point: Is MRI fusion biopsy the new gold standard for diagnosis?

April 10, 2018

Studies provide clear evidence to support MRI fusion biopsy’s use as the gold standard for men at risk for prostate cancer diagnosis following an initial negative biopsy.

Counterpoint: Is MRI fusion biopsy the new gold standard for diagnosis?

April 09, 2018

Limitations of MRI fusion biopsy include its cost, interobserver variability, and low diagnostic accuracy for clinically significant cancer in the anterior prostate.

Point: Is HIFU for low-risk prostate Ca ready for prime time?

April 08, 2018

Evidence shows HIFU can provide cancer control outcomes comparable to those associated with radical prostatectomy or radiation therapy in properly selected patients.

Counterpoint: Is HIFU for low-risk prostate Ca ready for prime time?

April 07, 2018

Recommending either whole-gland or focal HIFU cannot be justified when their pros and cons are judged relative to the appropriate comparator.

Point: Is stand-alone white light cystoscopy a thing of the past?

April 06, 2018

Based on recent developments with blue light cystoscopy, the use of white light cystoscopy alone is now considered suboptimal as a diagnostic tool.

Counterpoint: Is stand-alone white cystoscopy a thing of the past?

April 05, 2018

More evidence is needed before blue light cystoscopy becomes the standard of care for diagnosis and treatment and renders white light cystoscopy obsolete.

Point: Renal mass biopsy: Is it necessary for localized tumors?

April 05, 2018

Biopsy decreases overall uncertainty, is safe, fairly accurate, relatively inexpensive, and improves shared decision-making with patients.

Counterpoint: Renal mass biopsy: Is it necessary for localized tumors?

April 04, 2018

Renal mass biopsy provides actionable information, but only under specific circumstances-yet it is an increasingly necessary part of the nuanced patient discussion.